×
Merck Revenue 2010-2025 | MRK
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Merck revenue for the twelve months ending March 31, 2025 was
$63.922B
, a
4.1% increase
year-over-year.
Merck annual revenue for 2024 was
$64.168B
, a
6.74% increase
from 2023.
Merck annual revenue for 2023 was
$60.115B
, a
1.4% increase
from 2022.
Merck annual revenue for 2022 was
$59.283B
, a
21.72% increase
from 2021.
View More
Merck Revenue 2010-2025 | MRK
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Merck annual revenue for 2024 was
$64.168B
, a
6.74% increase
from 2023.
Merck annual revenue for 2023 was
$60.115B
, a
1.4% increase
from 2022.
Merck annual revenue for 2022 was
$59.283B
, a
21.72% increase
from 2021.
Related Stocks
Company Name
Market
Cap
Eli Lilly (LLY)
$796.4B
Johnson & Johnson (JNJ)
$379.5B
AbbVie (ABBV)
$306B
Novo Nordisk (NVO)
$260.6B
Roche Holding AG (RHHBY)
$248.1B
Novartis AG (NVS)
$234.2B
Sanofi (SNY)
$128.6B
Pfizer (PFE)
$125.6B
Bayer (BAYRY)
$23.7B
Innoviva (INVA)
$1.1B